BrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOw...

Press/Media: Press / Media

PeriodNov 9 2015

Media coverage

17

Media coverage

  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOw...
    Media name/outletCNN Money
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review In Phase 2 Trial Of NurOwn® In ALS
    Media name/outletTheStreet.com
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletReuters
    CountryUnited Kingdom
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletIndividual.com
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletSearchBug
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletTown Hall
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletFinancial Content
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletRCL Advisors
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletWorldNetDaily
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletCrawford Financial Planning
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletFreshnews.com
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletTickerTech.com
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outlet4 Traders
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletAriva.de
    CountryGermany
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletIndianapolis Business Journal
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn® in ALS
    Media name/outletPR Newswire
    CountryUnited States
    Date11/9/15
    PersonsCarlayne E Jackson
  • TitleBrainStorm Cell Therapeutics Announces Positive DSMB Review in Phase 2 Trial of NurOwn in ALS
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date11/9/15
    PersonsCarlayne E Jackson